You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 21, 2024

Details for New Drug Application (NDA): 077867

✉ Email this page to a colleague

« Back to Dashboard

NDA 077867 describes SOJOURN, which is a drug marketed by Piramal Critical and is included in one NDA. It is available from two suppliers. Additional details are available on the SOJOURN profile page.

The generic ingredient in SOJOURN is sevoflurane. There are five drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the sevoflurane profile page.
Summary for 077867
Applicant:Piramal Critical
Formulation / Manufacturing:see details
Pharmacology for NDA: 077867
Physiological EffectGeneral Anesthesia
Suppliers and Packaging for NDA: 077867
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SOJOURN sevoflurane LIQUID;INHALATION 077867 ANDA Piramal Critical Care Inc 66794-012 66794-012-10 100 mL in 1 BOTTLE, GLASS (66794-012-10)
SOJOURN sevoflurane LIQUID;INHALATION 077867 ANDA Piramal Critical Care Inc 66794-012 66794-012-25 250 mL in 1 BOTTLE, GLASS (66794-012-25)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:LIQUID;INHALATIONStrength100%
Approval Date:May 2, 2007TE:ANRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.